In addition, our analysis of ESR1 promoter methylation levels using UALCAN (http://ualcan.path.uab.edu/) unveiled a significant reduction in ESR1 promoter methylation levels in BLCA tumors [28] (Sfig.4 A). Here, ESR1 is linked to bladder transitional cell carcinoma.